Presented by: Sarah McGriff MD
Mayo Clinic

Introduction

Management of patients with obstructive lower urinary tracts symptoms (LUTS) after pelvic radiation can be challenging due to risk of post-operative stress urinary incontinence (SUI). The objective of this study was to assess efficacy and outcomes of a minimally invasive, reversible procedure (i.e., UroLift®) after pelvic radiation.

Materials

A retrospective review of patients who underwent UroLift® procedure at a Mayo Clinic facility from November 2019 to May 2023 after pelvic radiation was completed.

Results

,

Sixteen patients were included in the analysis. Comparison of pre-operative and post-operative International Prostate Symptom Scores (IPSS) demonstrated a significant improvement in quality of life after UroLift® by average of 1.89 on a 6-point scale (p=.0013, n=9). Only one patient developed de novo urinary retention. Four patients that were intermittently catheterizing pre-operatively were able to decrease daily catheterization rate. Importantly, none of the patients developed post-operative SUI requiring immediate removal of UroLift® implants.

Conclusion

UroLift® is a safe and efficacious procedure to treat obstructive LUTS after pelvic radiation.

Funding

None

Lead Authors

J. Nicholas Warner, MD
Mayo Clinic